We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Explains the taxes and benefits applicable to ultra low emission vehicles (ULEVs).
Notice relating to the proposed acquisition of Ultra Electronics Holdings plc by Cobham Ultra Acquisitions Limited.
Science advice note: What is the evidence base for plausible biological mechanisms for health impacts of ultra-processed foods (UPF)? and Evidence review of epidemiology and clinical trials in relation to health impacts of ultra-processed food.
Explains the main elements of a £500 million package to support the development and use of ultra low emission vehicles (ULEVs) in the UK.
This report synthesises evidence on microcredit for the ultra-poor
A. Menarini Farmaceutica Internazionale Srl is recalling a specific batch as a precautionary measure due to the distribution of Invokana 300mg in Northern Ireland in packaging intended for the Greek market.
Employment Appeal Tribunal Judgment of Judge Shanks on 16 April 2024.
Ultra Low Emission Taxi Infrastructure Scheme competition awards to local authorities for low emission chargepoint infrastructure.
Bristol-Myers Squibb Pharmaceuticals Limited has informed the MHRA that a potential product quality issue has been detected, relating to incomplete crimping of the metal crimp cap of OPDIVO 10mg/mL concentrate for solution for infusion (nivolumab) (1VLX10ML).
Check which electric (plug-in) and hybrid vans, trucks and motorbikes are available for a grant.
Employment Appeal Tribunal Judgment of Judge Tayler on 12 April 2024.
medac GmbH (t/a medac Pharma LLP) is recalling the product for the batch specified in this notification due to particles detected during long-term stability tests.
Product Safety Report for Esapharma Movate Steroid Cream presenting a serious chemical risk.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.